|1.||Cheng, Jun: 1 article (06/2015)|
|2.||Liang, Jinqiu: 1 article (06/2015)|
|3.||Liu, Shun-Ai: 1 article (06/2015)|
|4.||Li, Hongjie: 1 article (06/2015)|
|5.||Liang, Pu: 1 article (06/2015)|
|6.||Wang, Qi: 1 article (06/2015)|
|7.||Pang, Lin: 1 article (06/2015)|
|8.||Meng, Yixing: 1 article (06/2015)|
|9.||Cao, Jinfeng: 1 article (06/2015)|
|10.||Lu, Hongping: 1 article (06/2015)|
|1.||Breast Neoplasms (Breast Cancer)
08/01/2007 - "The study included patients with intermediate lesions (i.e., 25-50%) in unprotected LMCAs, with no previous evidence of associated ischemia. "
03/01/1987 - "BAEP and SEP monitoring failed to identify ischemic events in 4 patients with neurological findings of brain stem ischemia immediately after operation (i.e., 25% false-negative studies).(ABSTRACT TRUNCATED AT 250 WORDS)"
05/01/2015 - "During childhood, the 50th centiles for all studies lay in the middle of the International Obesity Task Force normal weight range, but during adulthood, the age when a 50th centile first entered the overweight range (i.e., 25-29.9 kg/m2) decreased across NSHD, NCDS, and BCS from 41 to 33 to 30 years in males and 48 to 44 to 41 years in females. "
03/01/2011 - "Subjects were stratified by fasting leptin into two groups (control, <12.7 ng mL(-1) vs. hyperleptenimic, e_< 12.7 ng mL(-1)) and BMI (normal weight, < 25 kgm(-2) vs. overweight/obese, BMI e_< 25 kg m(-2)). "
|4.||Urinary Bladder Neoplasms (Bladder Cancer)
02/01/2007 - "ELISAs showed in 'blinded studies' that ABCA5 was a highly sensitive (>98% sensitivity) urine diagnostic marker for HGPIN in biopsy-positive patients (n=107) at a 'cutoff' of 25 ng/mL. ABCA5 was present at very low levels (i.e., <25 ng/mL) in the urine of patients diagnosed with benign prostatic hyperplasia (n=79) or prostatitis or kidney and bladder cancer (>86% specificity). "
11/15/2010 - "Conditional logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) of bladder cancer by a priori categories of baseline serum 25-hydroxyvitamin D [25(OH)D; i.e., <25, 25 to <37.5, 37.5 to <50, ≥50 nmol/L] and by season-specific quartiles. "
|5.||Sarcoma (Soft Tissue Sarcoma)
07/15/1989 - "The treatment response rate of soft tissue sarcomas in the randomized study of Adriamycin (Adria Laboratories, Columbus, OH) regimens was slightly higher for those with lower grade sarcomas, i.e., 25% (four of 16) response rate for Grade 1 lesions; 22% (17/77) for Grade 2, and 21% (35/170) for Grade 3. When adjusted for type of sarcoma, there was no noticeable difference between Grade 1-2 versus 3 in response rate. "
|9.||althiazide drug combination spironolactone